trending topics
market reports
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
Zimbabwe buoyed by Chinese jabs
2021-12-31
-
AI expected to detect heart disease via selfies: Chinese researchers
BEIJING, Aug. 31 (Xinhua) -- Chinese medicine experts have been cooperating with computer scientists to develop AI-powered technologies that can detect coronary artery disease through facial images.
2020-09-01Innovation -
China approves patent to COVID-19 vaccine
China has granted its first COVID-19 vaccine patent to the adenovirus vector vaccine developed by Chen Wei of the Academy of Military Medical Sciences and Chinese biotech company CanSino Biologics.
2020-08-20Innovation -
Medical equipment makers step up innovation
China's medical manufacturing industry managed to maintain its momentum amid the COVID-19 pandemic, while boosting nation's efforts of bettering its manufacturing sector and its role in the global medical supply chain, industry experts said.
2020-06-23InnovationMedical Device -
Chinese-developed inactivated COVID19 vaccine becomes 1st worldwide to report positive response
A Chinese-developed inactivated vaccine for COVID-19 has presented positive preliminary results in phase one and two clinical trials, becoming the first vaccine candidate in the world to show favorable immunogenicity and safety.
2020-06-18Innovation -
COVID-19 vaccine could arrive before year's end
Two COVID-19 vaccine candidates with the China National Biotec Group (CNBG) have been proven safe in current clinical trials and could be available by the end of the year or early 2021, Yang Xiaoming, president of CNBG said in a report on Thursday.
2020-05-18Innovation -
Innovation helps stop COVID-19 at China's borders
BEIJING, April 15 (Xinhua) -- "Ding!" It's the sound of Customs officers scanning the electronic health codes of travelers in the exit-entry hall before allowing them into the country.
2020-04-16Innovation -
Shanghai scientists make discovery in gene editing approach
Shanghai scientists have found in lab tests that a novel gene editing approach could for the first time regenerate retinal ganglion cells and therefore restore sight of mice that suffer from permanent visual impairment.
2020-04-09Innovation